The injected animal can suffer from blood clots and strokes, potentially leading to death.
According to the U.S. Food and Drug Administration (FDA), intravenous therapy products used in animals are recalled nationwide in the United States in accordance with concerns about the potential presence of particulate matter.
The injected solution is used to rehydrate or maintain the hydration of the animal. It replaces lost fluids and helps restore electrolyte balance. However, the company warned that using injections containing particulate matter “can lead to serious adverse events.”
Potential complications include “brain obstruction where veins, granulomas, and vascular obstructions in the heart, lungs or brain can cause stroke or life-threatening thrombotic events, including death.”
“The frequency and severity of these adverse events can vary depending on a variety of factors, including the size and number of particles in the formulation, the patient’s comorbidity (such as age, compromised organ function), and the presence or absence of vascular abnormalities.”
This item is packaged in two units of 5 liter IV bags per case, with lot code #C2411061 and expiration dates of November 2026. It was distributed throughout the United States between December 31, 2024 and February 28, 2025.
Nova-Tech identified problems while visually inspecting the product for stability testing. So far, no adverse events have been reported.
The company “notifies distributors and customers via email and regular mail and arranges returns for all recalled products.”
Additionally, the announcement shows that veterinarians who have been injected with stock should return to their distributors.
Some of the possible symptoms of adverse events include paralysis, vomiting, pain, breathing work, loss of consciousness, reduced activity levels, swelling, fever, and weakness.
“If you observe any of these or other signs of an animal that may have been administered this product, contact your veterinarian as soon as possible.”
Consumers with a query about a recall can contact the company at 308-381-8841.
The FDA previously issued a recall of breastfeeding Ringer injections, citing the risk of contamination.